PIK3R3 and neoplasm: Specifically, the authors identify a gene fusion, CARD11–PIK3R3, which enhances CARD11‐BCL10‐MALT1 (CBM) complex signaling, cytokine production, and anti‐tumor efficacy of therapeutic T cells in immunotherapy‐refractory models.